Pharmacokinetics and tissue distribution of gentiopicroside following oral and intravenous administration in mice

Eur J Drug Metab Pharmacokinet. 2004 Jul-Sep;29(3):199-203. doi: 10.1007/BF03190598.

Abstract

The pharmacokinetics and tissue distribution of Gentiopicroside (GPS), one of the major active components of the Gentiana species of medicinal plants, was studied following oral and intravenous administration in mice. The distribution of GPS in mice after oral and intravenous doses could be fitted to a two-compartments open model. The serum half-life of GPS was 6.1 h and 2.8 h for intravenous and oral administration, respectively. The Tmax of GPS after oral administration was 0.50 h, and the bioavailability was 39.6%. The AUC gradient in individual tissues following intravenous administration was kidney >serum >liver >spleen >lung >thymus >fat >heart >muscle >stomach >intestinal >brain. The MRT gradient was muscle >serum >lung >spleen >lung >intestinal>heart >stomach >brain >liver >thymus >kidney >fat. Overall the data show that GPS could be absorbed rapidly in mice, but with a low bioavailability, and could distribute to tissues extensively, but was generally cleared quickly with short MRTs. The study demonstrates the need for repeated dosage, or better, a slow release formulation as an ideal means of administering GPS.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Female
  • Gentiana*
  • Glucosides / administration & dosage*
  • Glucosides / pharmacokinetics*
  • Injections, Intravenous
  • Iridoid Glucosides
  • Iridoids / administration & dosage*
  • Iridoids / pharmacokinetics*
  • Male
  • Mice
  • Pyrans / administration & dosage*
  • Pyrans / pharmacokinetics*
  • Tissue Distribution / drug effects
  • Tissue Distribution / physiology

Substances

  • Glucosides
  • Iridoid Glucosides
  • Iridoids
  • Pyrans
  • gentiopicroside